These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16582507)

  • 1. [Diagnostic imaging of skeletal metastases].
    Koizumi M; Koyama M
    Clin Calcium; 2006 Apr; 16(4):573- 80. PubMed ID: 16582507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic imaging of skeletal metastases].
    Koizumi M; Koyama M
    Nihon Rinsho; 2006 Sep; 64(9):1731-7. PubMed ID: 16972688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms and treatment of bone metastasis.
    Clines GA; Guise TA
    Expert Rev Mol Med; 2008 Mar; 10():e7. PubMed ID: 18321396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone imaging in prostate cancer.
    Dotan ZA
    Nat Clin Pract Urol; 2008 Aug; 5(8):434-44. PubMed ID: 18682719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone metastases of malignant tumors--diagnostic strategy with reference to recent examination techniques].
    Linden A; Schicha H
    Med Klin (Munich); 1992 Jan; 87(1):39-41. PubMed ID: 1545769
    [No Abstract]   [Full Text] [Related]  

  • 11. Distal skeletal metastases.
    Barrionuevo MA; Rillo OL
    J Clin Rheumatol; 2006 Jun; 12(3):148-50. PubMed ID: 16755247
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome.
    Hindié E; Zanotti-Fregonara P; Keller I; Duron F; Devaux JY; Calzada-Nocaudie M; Sarfati E; Moretti JL; Bouchard P; Toubert ME
    Endocr Relat Cancer; 2007 Sep; 14(3):799-807. PubMed ID: 17914109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can ultrasound detect skeletal metastases?].
    Doringer E; Ferner R; Feurstein M; Kranzinger M; Schmoller H
    Ultraschall Med; 1990 Feb; 11(1):29-32. PubMed ID: 2181655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
    Vessella RL; Corey E
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthopedic surgery implications of breast cancer.
    Marulanda GA; Mont MA; Lucci A; Letson GD; Khakpour N
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):949-56. PubMed ID: 18533804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
    Le Gall C; Bellahcène A; Bonnelye E; Gasser JA; Castronovo V; Green J; Zimmermann J; Clézardin P
    Cancer Res; 2007 Oct; 67(20):9894-902. PubMed ID: 17942921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of bone metastases.
    Oliver TB; Bhat R; Kellett CF; Adamson DJ
    J R Coll Physicians Edinb; 2011 Dec; 41(4):330-8. PubMed ID: 22184572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Wnts in bone metastases.
    Hall CL; Keller ET
    Cancer Metastasis Rev; 2006 Dec; 25(4):551-8. PubMed ID: 17160558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RANK/RANKL/OPG triad in cancer-induced bone diseases.
    Dougall WC; Chaisson M
    Cancer Metastasis Rev; 2006 Dec; 25(4):541-9. PubMed ID: 17180711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.